Caxton Associates (New York)’s Federated Hermes FHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,377
Closed -$300K 479
2023
Q2
$300K Buy
+8,377
New +$324K 0.04% 344
2020
Q4
Sell
-24,778
Closed -$533K 203
2020
Q3
$533K Buy
24,778
+14,520
+142% +$344K 0.06% 110
2020
Q2
$243K Buy
+10,258
New +$227K 0.02% 322
2020
Q1
Sell
-6,325
Closed -$206K 460
2019
Q4
$206K Buy
+6,325
New +$206K 0.03% 353
2015
Q1
Sell
-50,000
Closed -$1.65M 172
2014
Q4
$1.65M Buy
+50,000
New +$1.55M 0.13% 97

Other funds holding FHI

Caxton Associates (New York)'s FHI Position: Q3 2023 in Review

Caxton Associates (New York) sold out of Federated Hermes (FHI) in Q3 2023, closing a stake of 8,377 shares — an estimated $300K sold.

Caxton Associates (New York) first reported a position in FHI in Q4 2014 and held it in 5 quarters. The position peaked at $1.65M in Q4 2014. 308 funds tracked by Wall St. Rank hold FHI as of Q3 2023.

  • Caxton Associates (New York) reported no remaining Federated Hermes position as of Q3 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 8,377 Federated Hermes shares in Q3 2023, an estimated $300K.
  • Caxton Associates (New York) first reported a position in Federated Hermes in Q4 2014 and held it in 5 quarters.
  • Caxton Associates (New York)'s Federated Hermes position peaked at $1.65M in Q4 2014.
  • 308 funds tracked by Wall St. Rank held Federated Hermes as of Q3 2023.

Based on Caxton Associates (New York)'s 13F filing for Q3 2023, filed 14 Nov 2023.